Bernhardt G. Zeiher

机构：Astellas Pharma (United States)

发表论文 47 篇 · 总被引 3996 次 · h-index 19

代表论文

• Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial (2015 · The Lancet · 被引 1006)
• Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis (2016 · The Lancet Infectious Diseases · 被引 711)
• Mechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na+ channel (1995 · Cell · 被引 414)
• Neutrophil elastase inhibition in acute lung injury: Results of the STRIVE study (2004 · Critical Care Medicine · 被引 352)
• A mouse model for the delta F508 allele of cystic fibrosis. (1995 · Journal of Clinical Investigation · 被引 300)
• Predicting Postoperative Pulmonary Function in Patients Undergoing Lung Resection (1995 · CHEST Journal · 被引 160)